Bayer Co.Lab

On ??????????????????, ?????????? ?????? ???????? ???? - ?? ????, please join the Bayer Co.Lab Cambridge for its first Vendor Showcase! This event, taking place on the ?????? ?????????? ???? ?????? ???????? ???????????? ???? ??????????????????, will feature representatives from: FUJIFILM Irvine Scientific, Kvantify, Axxam, Abzena, Avastus Preclinical Services, Viralgene, Evonik Industries, Broken String Biosciences, Unchained Labs, and Champions Oncology. Stop by, enjoy some food/treats, and hear from these vendors about how their offerings and services might be of use to your team! Register here: https://lu.ma/xtewtjkq

Europe has a lot to offer and it showed at BIO Europe Spring this week. I met many brilliant people, re-connected with familiar faces, ideated about new business opportunities, was pleasantly surprised by the amount of money & desire that is available for investment into European ventures, and am leaving with a strong sense of pride and optimism about Europe's role on the global life sciences stage. This community is strong and Bayer Co.Lab is excited to be a part of it, by shaping, accelerating and connecting innovations within Europe and to/from the global stage. A big thank you to WuXi AppTec for inviting me to present Bayer Co.Lab at their reception. Excellent moderation by Hui Cai, and wonderful to share the stage with Francesco De Rubertis, Alain Huriez and Christoph P., each sharing our different perspectives about the importance of collaboration to bring novel medicines to patients. Looking forward to Vienna in the autumn! EBD Group #bioeuropespring #innovation #startups #lifescience #biotech #entrepreneurship

?? Huge congratulations to?AccurEdit Therapeutics?— our resident startup at?Bayer Co.Lab Shanghai?— on securing?Orphan Drug Designation (ODD)?from the U.S. FDA for?ART001, the?world’s first LNP-based in vivo gene editing product?to achieve IND clearances in?both China and the U.S.! ?? ??ART001 addresses?transthyretin amyloidosis (ATTR), a rare and life-threatening disease, with precision science that tackles unmet medical needs. As?China’s first?LNP-based in vivo gene editing therapy to enter human trials August 2023 and the?only dual-approved development drug targeting ATTR, ART001 sets a new benchmark for innovation. ?? At?Bayer Co.Lab, we’re honored to empower biotech pioneers like AccurEdit, whose work pushes the boundaries of what’s possible. By leveraging Bayer’s?global expertise, networks, and resources, we’re committed to accelerating breakthroughs that transform patient lives worldwide. ???? ? ???Bravo, Team AccurEdit?— your relentless drive inspires us all to redefine what’s possible! ? ???Calling biotech innovators - Join the?Bayer Co.Lab community?to scale your boldest ideas. Together, let’s turn groundbreaking science into?life-changing solutions #GeneEditing #PrecisionMedicine #BreakthroughInnovation #BayerCoLab #Incubation https://lnkd.in/gXQcURbi

Join Morrison Foerster and the Bayer Co.Lab Cambridge ???????????????? for Session 2 of the ScaleUp: Boston series as we celebrate the start of spring with fresh perspectives, innovative ideas, and seasonal dishes that will inspire and refresh! Speakers Jim Krenn and Andrew Dixon will touch upon the process, key concepts, and main terms behind venture capital investments in the life sciences space. Register here: https://lnkd.in/d2hWgWb3

???Bayer Co.Lab’s Debut at BIOCHINA: Empowering China’s Biotech Innovation This year marked?Bayer Co.Lab’s first participation?at?BIOCHINA, China’s largest biotech convention, bringing together?2,000+ biotech companies?and?30,000+ participants from across China and the globe. As a global partner to China’s innovation ecosystem, we leveraged this milestone to connect with the brightest minds shaping the future of healthcare:?scientists, entrepreneurs and investors?driving the emerging biotech innovation in China. ?? 1:1 Partnering Meetings: We met with biotech founders and innovators to explore how Bayer Co.Lab’s?global network, resources, and expertise?can empower startups to scale breakthroughs from China to the world. ???Deep Dive into Innovation: From precision drug discovery to next generation modalities, we witnessed the thriving biotech ecosystem in China — now a?key contributor to global biotech innovation. A heartfelt thank you to everyone who stopped by and engaged with our team into the conversations during the three-day event — your vision and energy inspire us daily. ???Ready to accelerate your innovation and start-ups??Join us at Bayer Co.Lab as a global life science incubator network. #BayerCoLab #BIOCHINA2025 #BiotechInnovation #Incubation #TeamBayer

Thanks to all who attended the first installment of the 2025 ScaleUp: Boston series with Morrison Foerster. A special thank you to Jesse Nevarez for his presentation "Most Common Legal and Business Mistakes of Startup Entrepreneurs". We invite you to join us for the second presentation next Thursday, March 20th titled "Raising Venture Capital Investment" with?Jim Krenn?and?Andrew Dixon. Use the link below to register!

Thank you,?Christoph and the?CD&O leadership team, for energizing the inaugural?Expert Talk Live?event at?Bayer Co.Lab Shanghai! Your global perspectives on accelerating clinical development innovation sparked truly inspiring dialogues with China’s biotech ?pioneers. The dynamic exchange with local innovators underscored the power of collaboration in turning bold ideas into patient-centric breakthroughs. We’re excited to nurture the seeds planted during these discussions and drive forward the partnerships that hold immense promise to reshape the future of healthcare. #TeamBayer #BiotechInnovation #ClinicalDevelopment #BayerCoLab

1st tenant moves into Bayer Co.Lab Berlin! This is more than just a facility milestone, it’s a significant step forward in our goal to accelerate the journey of Europes top scientists and entrepreneurs. To build a space with surrounding support mechanisms where brilliant ideas can be brought to life. And to create a thriving community of boundary pushing innovators (Bayer included) working together for patient benefit. MyoPax, welcome aboard! #startup #innovation #collaboration #lifesciences #biotech #cellandgenetherapy #incubator

???Expert Talk at Bayer Co.Lab Shanghai: Connecting, Sharing and Inspiring Innovation We’re thrilled to kick off our?Expert Talk live event at Bayer Co.Lab Shanghai - a dynamic platform connecting biotech start-ups with Bayer and industry leaders to inspiring innovation. ?? Earlier this week, we welcomed?Christoph Koenen and the Clinical Development & Operations (CD&O) leadership team from Bayer Pharmaceuticals, for an energizing session focused on accelerating innovation in clinical development. ??This event featured a keynote by Christoph on innovation and clinical development & operations. His insights equipped biotechs with strategies to navigate through challenges in clinical development. ??As a pillar of Bayer’s R&D capability clusters, the CD&O team brings profound domain knowledge to ensure operational efficiency, quality, cost & speed. ???Through interactive sessions, our resident companies and biotech representatives gained tailored advice to advance their pipelines and leveraged Bayer’s global insights to refine their clinical strategies. ?? This onsite event marks a?new chapter?of our Expert Talk initiative (including virtual Expert Monday series) , designed to bridge Bayer’s world-class expertise to the vibrant biotech ecosystem through our global Co.Lab network. ?? A heartfelt thank you to Christoph Koenen,?Pablo Arriagada, MD, MBA,?Thomas Miller, Astrid S. and?Paul Dai?for sharing your expertise and valuable insights to reinforce Bayer’s role as the?partner of choice?for biotech innovation. #BayerCoLab #ExpertTalk #BiotechInnovation #Incubation #ClinicalDevelopment

Welcome aboard, MyoPax! ???? We are thrilled to welcome MyoPax as the very first tenant at Bayer Co.Lab Berlin. MyoPax are pioneering muscle regeneration therapies using stem cell and gene editing technologies. With their inspiring work, they are laying the first bricks of what will soon become a thriving community of courageous innovators at Bayer Co.Lab Berlin. Verena Sch?wel, Mina Petkova and Eric Metzler - we are excited to have you on site!